US special counsel looks into alleged misconduct at Merck plant prepping to make J&J shot — and indifference from FDA
The US Office of Special Counsel has unveiled the details of a whistleblower complaint from a former FDA employee who alleged numerous violations at a Merck manufacturing plant in North Carolina that’s now being readied to make the J&J Covid-19 vaccine, even explaining how employees were soiling themselves to avoid bathroom breaks that would require them to leave manufacturing areas.
The OSC report, published Wednesday, features a letter from Arie Menachem, the former FDA inspector turned whistleblower, who claims that the agency learned of these violations, among others, in 2018, and didn’t act upon them. The report also alleges that Merck was intentionally destroying evidence of possible violations.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 106,500+ biopharma pros reading Endpoints daily — and it's free.